secwatch / observer
8-K filed April 4, 2024, 7:59 PM ET ticker SRXH CIK 0001471727
leadership confidence high sentiment neutral materiality 0.40

Director Arlene Dickinson resigns; CEO Kent Cunningham appointed to board

SRx Health Solutions, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kent Cunningham

Director
SRXH · SRx Health Solutions, Inc.
Effective
2024-04-03
Filed
April 4, 2024, 7:59 PM ET
On April 3, 2024, the Board appointed Kent Cunningham, the Company’s Chief Executive Officer, as a director of the Company, effective immediately,
Departed

Arlene Dickinson

Director
SRXH · SRx Health Solutions, Inc.
Effective
2024-04-01
Filed
April 4, 2024, 7:59 PM ET
Arlene Dickinson resigned from the Board of Directors (the “Board”) of Better Choice Company Inc., a Delaware corporation (the “Company”) and all committees of the Board effective as of April 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kent Cunningham was appointed as Director at SRx Health Solutions, Inc..

Action
appointed
Role
Director
Exact text from the filing
On April 3, 2024, the Board appointed Kent Cunningham, the Company’s Chief Executive Officer, as a director of the Company, effective immediately,
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Arlene Dickinson resigned as Director at SRx Health Solutions, Inc..

Action
resigned
Role
Director
Exact text from the filing
Arlene Dickinson resigned from the Board of Directors (the “Board”) of Better Choice Company Inc., a Delaware corporation (the “Company”) and all committees of the Board effective as of April 1, 2024.
View on SEC.gov

SRx Health Solutions, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-24-013130
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.